Lipomobilization effect of nonhydrazine type of monoamine oxidase inhibitors.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D004822:Epididymis / Q000187:drug effects / Q000378:metabolism; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005990:Glycerol / Q000097:blood; D006584:Hexamethonium Compounds / Q000494:pharmacology; D066298:In Vitro Techniques; D007773:Lactates / Q000097:blood; D008053:Lipid Mobilization / Q000187:drug effects*; D008297:Male; D051379:Mice; D010293:Pargyline / Q000494:pharmacology*; D010424:Pentobarbital / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013997:Time Factors; D014191:Tranylcypromine / Q000494:pharmacology*
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D006584:Hexamethonium Compounds; D007773:Lactates; D014191:Tranylcypromine; D012110:Reserpine; D010293:Pargyline; D011433:Propranolol; D010424:Pentobarbital; D005990:Glycerol